In this issue of Indication you can read about:
- The Danish Medicines Agency's new strategy 'Perspectives and challenges 2011-2016.
- How companies and scientists can save resources by applying for approval of a clinical trial through the European Voluntary Harmonisation Procedure.
- The daily work of evaluating serious side effects.
- The differences between men and women - and whether these differences should be reflected in the development of new medicine.
Indication, 31 March 2011